We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFHD
4251
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$11K ﹤0.01%
478
+447
+1,442% +$9.51K
OYST
4252
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$11K ﹤0.01%
920
-973
-51% -$11.6K
RBCN
4253
DELISTED
Rubicon Technology, Inc.
RBCN
$11K ﹤0.01%
1,176
-508
-30% -$4.55K
GLHA
4254
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$11K ﹤0.01%
1,088
+912
+518% +$8.86K
AKUS
4255
DELISTED
Akouos Inc
AKUS
$11K ﹤0.01%
2,322
-4,381
-65% -$25.7K
AUS
4256
DELISTED
Austerlitz Acquisition Corporation I
AUS
$11K ﹤0.01%
1,099
-1,062
-49% -$10.3K
AXU
4257
DELISTED
Alexco Resource Corp
AXU
$11K ﹤0.01%
6,682
+6,632
+13,264% +$11K
ATHX
4258
DELISTED
Athersys, Inc. Common Stock
ATHX
$11K ﹤0.01%
708
+232
+49% +$4.85K
ENDP
4259
DELISTED
Endo International plc
ENDP
$11K ﹤0.01%
4,813
+724
+18% +$2.12K
SMED
4260
DELISTED
Sharps Compliance Corp
SMED
$11K ﹤0.01%
1,792
+552
+45% +$3.47K
NSEC
4261
DELISTED
National Security Group Inc
NSEC
$11K ﹤0.01%
722
-72
-9% -$1.07K
RIBT
4262
DELISTED
RiceBran Technologies
RIBT
$11K ﹤0.01%
2,357
+247
+12% +$908
UBA
4263
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$11K ﹤0.01%
582
-13,436
-96% -$263K
THER
4264
DELISTED
THERATECHNOLOGIES INC COM
THER
$11K ﹤0.01%
4,319
-1,863
-30% -$4.75K
ABOS icon
4265
Acumen Pharmaceuticals
ABOS
$193M
$10K ﹤0.01%
2,555
-3,968
-61% -$21.6K
ADAP
4266
DELISTED
Adaptimmune Therapeutics
ADAP
$10K ﹤0.01%
4,713
-1,215
-20% -$3.28K
ADCT icon
4267
ADC Therapeutics
ADCT
$128M
$10K ﹤0.01%
737
-1,452
-66% -$23K
AHT
4268
Ashford Hospitality Trust
AHT
$20.8M
$10K ﹤0.01%
101
-159
-61% -$14.2K
ALOT icon
4269
AstroNova
ALOT
$227M
$10K ﹤0.01%
648
+57
+10% +$803
AMLX icon
4270
Amylyx Pharmaceuticals
AMLX
$2.41B
$10K ﹤0.01%
+711
New +$16.1K
GOLD
4271
Gold.com Inc
GOLD
$1.28B
$10K ﹤0.01%
258
-108
-30% -$3.69K
ANTX icon
4272
AN2 Therapeutics
ANTX
$226M
$10K ﹤0.01%
+653
New +$9.91K
ARLO icon
4273
Arlo Technologies
ARLO
$1.54B
$10K ﹤0.01%
1,168
-3,352
-74% -$30.8K
ARTNA icon
4274
Artesian Resources
ARTNA
$369M
$10K ﹤0.01%
209
-34
-14% -$1.59K
BDTX icon
4275
Black Diamond Therapeutics
BDTX
$116M
$10K ﹤0.01%
3,558
-7,691
-68% -$28.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.